TNF Pharmaceuticals, Inc.
TNFA
$0.22
$0.02814.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.06M | -1.93M | -9.57M | -9.80M | -2.36M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 710.30K | 381.50K | 6.66M | 7.55M | -1.72M |
| Change in Net Operating Assets | 589.80K | -2.08M | 240.40K | 336.90K | 2.15M |
| Cash from Operations | -764.10K | -3.63M | -2.67M | -1.91M | -1.93M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.10M | 3.09M | -11.02M | 732.00K | 5.93M |
| Cash from Investing | 1.10M | 3.09M | -11.02M | 732.00K | 5.93M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 14.00M | -- | 0.00 |
| Repurchase of Preferred Stock | 0.00 | 0.00 | 0.00 | -73.50K | -89.60K |
| Total Dividends Paid | -1.36M | -- | 0.00 | -1.13M | -1.45M |
| Other Financing Activities | -- | 68.10K | 0.00 | -68.10K | -77.10K |
| Cash from Financing | -1.36M | 1.20M | 14.00M | -1.28M | -1.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.02M | 656.30K | 310.40K | -2.46M | 2.38M |